These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 23719495

  • 1. [Regulation of osteoclast differentiation by Wnt signals].
    Kobayashi Y.
    Clin Calcium; 2013 Jun; 23(6):831-8. PubMed ID: 23719495
    [Abstract] [Full Text] [Related]

  • 2. Roles of Wnt signals in bone resorption during physiological and pathological states.
    Maeda K, Takahashi N, Kobayashi Y.
    J Mol Med (Berl); 2013 Jan; 91(1):15-23. PubMed ID: 23111637
    [Abstract] [Full Text] [Related]

  • 3. Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis.
    Maeda K, Kobayashi Y, Udagawa N, Uehara S, Ishihara A, Mizoguchi T, Kikuchi Y, Takada I, Kato S, Kani S, Nishita M, Marumo K, Martin TJ, Minami Y, Takahashi N.
    Nat Med; 2012 Feb 19; 18(3):405-12. PubMed ID: 22344299
    [Abstract] [Full Text] [Related]

  • 4. Regulation of bone metabolism by Wnt signals.
    Kobayashi Y, Uehara S, Udagawa N, Takahashi N.
    J Biochem; 2016 Apr 19; 159(4):387-92. PubMed ID: 26711238
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
    Chikazu D, Katagiri M, Ogasawara T, Ogata N, Shimoaka T, Takato T, Nakamura K, Kawaguchi H.
    J Bone Miner Res; 2001 Nov 19; 16(11):2074-81. PubMed ID: 11697804
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Canonical Wnt signaling in osteoblasts is required for osteoclast differentiation.
    Glass DA, Karsenty G.
    Ann N Y Acad Sci; 2006 Apr 19; 1068():117-30. PubMed ID: 16831912
    [Abstract] [Full Text] [Related]

  • 9. Regulatory mechanism of osteoclastogenesis by RANKL and Wnt signals.
    Takahashi N, Maeda K, Ishihara A, Uehara S, Kobayashi Y.
    Front Biosci (Landmark Ed); 2011 Jan 01; 16(1):21-30. PubMed ID: 21196156
    [Abstract] [Full Text] [Related]

  • 10. IL-1 plays an important role in the bone metabolism under physiological conditions.
    Lee YM, Fujikado N, Manaka H, Yasuda H, Iwakura Y.
    Int Immunol; 2010 Oct 01; 22(10):805-16. PubMed ID: 20679512
    [Abstract] [Full Text] [Related]

  • 11. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
    Häusler KD, Horwood NJ, Chuman Y, Fisher JL, Ellis J, Martin TJ, Rubin JS, Gillespie MT.
    J Bone Miner Res; 2004 Nov 01; 19(11):1873-81. PubMed ID: 15476588
    [Abstract] [Full Text] [Related]

  • 12. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
    Qiang YW, Barlogie B, Rudikoff S, Shaughnessy JD.
    Bone; 2008 Apr 01; 42(4):669-80. PubMed ID: 18294945
    [Abstract] [Full Text] [Related]

  • 13. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation.
    Glass DA, Bialek P, Ahn JD, Starbuck M, Patel MS, Clevers H, Taketo MM, Long F, McMahon AP, Lang RA, Karsenty G.
    Dev Cell; 2005 May 01; 8(5):751-64. PubMed ID: 15866165
    [Abstract] [Full Text] [Related]

  • 14. Canonical Wnt signaling inhibits osteoclastogenesis independent of osteoprotegerin.
    Albers J, Keller J, Baranowsky A, Beil FT, Catala-Lehnen P, Schulze J, Amling M, Schinke T.
    J Cell Biol; 2013 Feb 18; 200(4):537-49. PubMed ID: 23401003
    [Abstract] [Full Text] [Related]

  • 15. Administration of zinc inhibits osteoclastogenesis through the suppression of RANK expression in bone.
    Hie M, Tsukamoto I.
    Eur J Pharmacol; 2011 Oct 01; 668(1-2):140-6. PubMed ID: 21806983
    [Abstract] [Full Text] [Related]

  • 16. The role of the Wnt/β-catenin pathway in the effect of implant topography on MG63 differentiation.
    Wang W, Zhao L, Ma Q, Wang Q, Chu PK, Zhang Y.
    Biomaterials; 2012 Nov 01; 33(32):7993-8002. PubMed ID: 22889483
    [Abstract] [Full Text] [Related]

  • 17. Involvement of WNT/β-catenin signaling in the treatment of osteoporosis.
    Rossini M, Gatti D, Adami S.
    Calcif Tissue Int; 2013 Aug 01; 93(2):121-32. PubMed ID: 23748710
    [Abstract] [Full Text] [Related]

  • 18. Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions.
    Quinn JM, Itoh K, Udagawa N, Hausler K, Yasuda H, Shima N, Mizuno A, Higashio K, Takahashi N, Suda T, Martin TJ, Gillespie MT.
    J Bone Miner Res; 2001 Oct 01; 16(10):1787-94. PubMed ID: 11585342
    [Abstract] [Full Text] [Related]

  • 19. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function.
    Takahashi N, Udagawa N, Suda T.
    Biochem Biophys Res Commun; 1999 Mar 24; 256(3):449-55. PubMed ID: 10080918
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.